Instrumentos para rastreio de transtornos mentais por substâncias psicoativas na atenção primária: revisão de escopo
Resumo
Objetivo: identificar na literatura os instrumentos para rastreio de transtornos mentais por substâncias psicoativas utilizados atualmente pelas equipes de Atenção Primária. Método: revisão de escopo seguindo recomendações do Joanna Briggs Institute Reviewers’ Manual, em diversas bases de dados, por meio de artigos publicados entre 1978 a abril de 2024. Resultados: de 10.701 artigos encontrados, 60 foram selecionados para análise. Foram identificados diversos instrumentos de rastreio, com especificidades para diferentes faixas etárias e substâncias psicoativas. Além disso, a maioria dos estudos concentrou-se em instrumentos para rastreio de transtornos por álcool. Conclusões: constatou-se o foco significativo no rastreio de álcool e a lacuna quanto à estratificação de risco e direcionamento de cuidado, importantes para intervenções mais precisas. É crucial validar instrumentos em diferentes contextos culturais e integrá-los aos sistemas de informação, melhorando o monitoramento e a avaliação das intervenções.
Referências
Tomé FDCP, Tomé LA, de Oliveira MSR, Tomé RL, Cheffer MH. Uso de substâncias psicoativas por estudantes de medicina durante a pandemia do coronavírus. Scientific Electronic Archives. 2022;15(6):58-63. DOI: https://doi.org/10.36560/15620221547
Paula MLD, Jorge MSB, Vasconcelos MGF, Albuquerque RA. Assistência ao usuário de drogas na atenção primária à saúde. Psicol. Estud. (Online). 2014;19:223-33. DOI: http://dx.doi.org/10.1590/1413-737222025006
Militão LF, Santos LI, Cordeiro GFT, Sousa KHJF, Peres MAA, Peters AA. Users of psychoactive substances: challenges to nursing care in the Family Health Strategy. Esc. Anna Nery Rev. Enferm. 2022;26:e20210429. DOI: https://doi.org/10.1590/2177-9465-EAN-2021-0429en
Moreira RMM, Oliveira EN, Lopes RE, Oliveira Lopes MV, Almeida PC, Aragão HL. Transtorno mental comum em usuários de substâncias psicoativas. Enferm. foco (Brasília). 2020;11(1):99-105. DOI: https://doi.org/10.21675/2357-707X.2020.v11.n1.2675
Moreira RMM. Mental disorder and suicide risk in psychoactive
substance users: an integrative review. SMAD, Rev. eletrônica saúde mental alcool drog. 2020;16(1):1-10. DOI https://pepsic.bvsalud.org/pdf/smad/v16n1/en_v16n1a16.pdf
Lacerda Neto JC, Silva JPB. Internações hospitalares por transtornos mentais e comportamentais devido ao uso de substâncias psicoativas no estado do Maranhão, Brasil. Rev. Bras. Pesqui. Saúde (Online). 2023;25(4):11-22. DOI: https://doi.org/10.47456/rbps.v25i4.40679
Carvalho AG, Oliveira EN, Moreira RMM, Lima GF, Vasconcelos MIO, Campos MP, et al. Risco de suicídio e transtorno mental comum em usuários de substâncias psicoativas residentes em comunidades terapêuticas. Contribuiciones a las Ciências Sociales. 2024;17(1):7917-34. DOI: https://doi.org/10.55905/revconv.17n.1-477
Drnach-Bonaventura GM, Moore DW, Scott GL, Cloutier RM, Pringle JL. Why substance use screening frequency matters in adult primary care. Substance Use & Addiction Journal. 2024;45(1):65–73. DOI: https://doi.org/10.1177/29767342231210112
Nakidde G, Kumakech E, Mugisha JF. Maternal mental health screening and management by health workers in southwestern Uganda: a qualitative analysis of knowledge, practices, and challenges. BMC Pregnancy Childbirth. 2023;23(1):477. DOI: https://doi.org/10.1186/s12884-023-05763-7
Pereira PLS, Quintela EHSX, Chiamulera TM, David AKF, Souza GA, Medeiros PKF, et al. Importância da implantação de questionários para rastreamento e diagnóstico precoce do transtorno do espectro autista (TEA) na atenção primária. Brazilian Journal Health Review. 2021;4(2):8364–77. DOI: https://doi.org/10.34119/bjhrv4n2-360
Roever L, Gomes-Neto M, Duràes AR, Reis PEO, Pollo-Flores P, Silva RML, et al. Compreendendo o GRADE: PICO e qualidade dos estudos. Rev. Soc. Bras. Clín. Méd. 2021;19(1):54–61. DOI: https://docs.bvsalud.org/biblioref/2022/03/1361752/54-61.pdf
Bruzeguini MV, Pereira TF, Pagel ML, Lemos TC, Prata ES, Cruz KC, et al. Screening and diagnostic tools for depressive disorders used in primary care: an integrative review. Rev. Bras. Med. Fam. Comunidade (Online). 2023;18(45):3817. DOI: https://doi.org/10.5712/rbmfc18(45)3817
Peters MDJ, Godfrey C, McInerney P, Balbini Soares C, Khalil H, Parker D. Chapter 11: Scoping Reviews. In: JBI. Reviewers Manual JBI; 2020. DOI: https://doi.org/10.46658/JBIMES-24-09
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372. DOI: https://doi.org/10.1136/bmj.n160
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. Joural of Clinical Epidemiology. 2016;75:40-6. DOI: https://doi.org/10.1016/j.jclinepi.2016.01.021
Ebersole AM, Gallup J, Rockwell A, Patel AD, Bonny AE. Implementing evidence-based, electronic, substance-use screening in a primary care clinic. Journal of Adolescent Health. 2023;73(1):127-32. DOI: https://doi.org/10.1016/j.jadohealth.2023.02.010
Goldschmidt L, Mncina B, Langa M, Rebello S, Budaza T, Tshabalala J, et al. AUDIT-C as a possible source of referral during the COVID-19 pandemic for participants presenting patterns of high-risk alcohol consumption in a South African township. BMC Public Health. 2023;23(1):1890. DOI: https://doi.org/10.1186/s12889-023-16775-5
Matson TE, Hallgren KA, Lapham GT, Oliver M, Wang X, Williams EC, et al. Psychometric performance of a substance use symptom checklist to help clinicians assess substance use disorder in primary care. JAMA Network Open. 2023;6(5). DOI: https://doi.org/10.1001/jamanetworkopen.2023.16283
McNeely J, McLeman B, Gardner T, Nesin N, Amarendran V, Farkas S, et al. Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients. Addiction Science & Clinical Practice. 2023;18(1):56. DOI: https://doi.org/10.1186/s13722-023-00404-y
Reddick B, Foli KJ, Coddington JA, Hountz D. Implementing a substance use screening protocol in rural federally qualified health centers. J Am Psychiatr Nurses Assoc. 2023;29(1):71-8. DOI: https://doi.org/10.1177/1078390320975493
Dzidowska M, Lee KK, Conigrave JH, Dobbins TA, Hummerston B, Wilson S, et al. Support for Aboriginal health services in reducing harms from alcohol: 2-year service provision outcomes in a cluster randomized trial. Addiction. 2022;117(3):796-803. DOI: https://doi.org/10.1111/add.15712
Matson TE, Lapham GT, Bobb JF, Oliver M, Hallgren KA, Williams EC, et al. Validity of the Single-Item Screen–Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care. JAMA Network Open. 2022;5(11). DOI: https://doi.org/10.1001/jamanetworkopen.2022.39772
O’Donnell A, Anderson P, Schmidt C, Braddick F, Lopez-Pelayo H, Mejía-Trujillo J, et al. Tailoring an evidence-based clinical intervention and training package for the treatment and prevention of comorbid heavy drinking and depression in middle-income country settings: the development of the SCALA toolkit in Latin America. Global Health Action. 2022;15(1):2080344. DOI: https://doi.org/10.1080/16549716.2022.2080344
Schøler PN, Søndergaard J, Barfod S, Nielsen AS. Danish feasibility study of a new innovation for treating alcohol disorders in primary care: the 15-method. BMC Primary Care. 2022;23(34). DOI: https://doi.org/10.1186/s12875-022-01639-5
Atkins DL, Cumbe VF, Muanido A, Manaca N, Fumo H, Chiruca P, et al. Validity and item response theory properties of the Alcohol Use Disorders Identification Test for primary care alcohol use screening in Mozambique (AUDIT-MZ). Journal of Substance Use & Addiction Treatment. 2021;127:108441. DOI: https://doi.org/10.1016/j.jsat.2021.108441
Levy S, Wisk LE, Chadi N, Lunstead J, Shrier LA, Weitzman ER. Validation of a single question for the assessment of past three-month alcohol consumption among adolescents. Drug and Alcohol Dependence. 2021;228:109026. DOI: https://doi.org/10.1016/j.drugalcdep.2021.109026
McNeely J, Adam A, Rotrosen J, Wakeman SE, Wilens TE, Kannry J, et al. Comparison of methods for alcohol and drug screening in primary care clinics. JAMA Network Open. 2021;4(5):e2110721. DOI: https://doi.org/10.1001/jamanetworkopen.2021.10721
Neufeld M, Rehm J, Bunova A, Gil A, Gornyi B, Rovira P, et al. Validation of a screening test for alcohol use, the Russian Federation. Bulletin of the World Health Organization. 2021;99(7):496. DOI: https://doi.org/10.2471/BLT.20.273227
Parthasarathy S, Kline-Simon AH, Jones A, Hartman L, Saba K, Weisner C, et al. Three-year outcomes after brief treatment of substance use and mood symptoms. Pediatrics. 2021;147(1):e2020009191. DOI: https://doi.org/10.1542/peds.2020-009191
Rossom RC, Sperl-Hillen JM, O’Connor PJ, Crain AL, Nightingale L, Pylkas A, et al. A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder. Addiction Science & Clinical Practice. 2021;16(1):37. DOI: https://doi.org/10.1186/s13722-021-00245-7
Tiet QQ, Moos RH. Screen of drug use: diagnostic accuracy for stimulant use disorder. Addictive Behaviors. 2021;112:106614. DOI: https://doi.org/10.1016/j.addbeh.2020.106614
Wallhed Finn S, Hammarberg A, Andreasson S, Jirwe M. Treating alcohol use disorders in primary care–a qualitative evaluation of a new innovation: the 15-method. Scandinavian Journal of Primary Health Care. 2021;39(1):51-9. DOI: https://doi.org/10.1080/02813432.2021.1882079
Maciel MED, Vargas DD. Criterion validity of the Key Question for screening at-risk alcohol use in primary healthcare. Rev. Esc. Enferm. USP. 2020;54. DOI: https://doi.org/10.1590/S1980-220X2018032503553
Mei C, Vaez K. Success factors for and barriers to integration of electronic mental health screening in primary care. Comput Inform Nurs. 2020;38(9):441-50. DOI: https://doi.org/10.1097/cin.0000000000000617
Adam A, Schwartz RP, Wu LT, Subramaniam G, Laska E, Sharma G, et al. Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool. Addiction Science & Clinical Practice. 2019;14:1-12. DOI: https://doi.org/10.1186/s13722-019-0167-z
Tiet QQ, Moos RH. Screen of drug use: Diagnostic accuracy for cannabis use disorder. Addictive Behaviors. 2019;95:184-8. DOI: https://doi.org/10.1016/j.addbeh.2019.02.010
Tiet QQ, Leyva YE, Moos RH. Screen of drug use: Diagnostic accuracy for opioid use disorder. Drug and Alcohol Dependence. 2019;198:176-9. DOI: https://doi.org/10.1016/j.drugalcdep.2019.01.044
Schwartz RP, McNeely J, Wu LT, Sharma G, Wahle A, Cushing C, et al. Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Use & Addiction Treatment. 2017;76:69-76. DOI: https://doi.org/10.1016/j.jsat.2017.01.013
Tiet QQ, Leyva YE, Moos RH, Smith B. Diagnostic accuracy of a two-item Drug Abuse Screening Test (DAST-2). Addictive Behaviors. 2017;74:112-7. DOI: https://doi.org/10.1016/j.addbeh.2017.06.008
D’Amico EJ, Parast L, Meredith LS, Ewing BA, Shadel WG, Stein BD. Screening in primary care: what is the best way to identify at-risk youth for substance use? Pediatrics. 2016;138(6):e20161717. DOI: https://doi.org/10.1542/peds.2016-1717
Kumar PC, Cleland CM, Gourevitch MN, Rotrosen J, Strauss S, Russell L, et al. Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients. Drug and Alcohol Dependence. 2016;165:38-44. DOI: https://doi.org/10.1016/j.drugalcdep.2016.05.030
Spear SE, Shedlin M, Gilberti B, Fiellin M, McNeely J. Feasibility and acceptability of an audio computer-assisted self-interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. Subst Abus. 2016;37(2):299-305. DOI: https://doi.org/10.1080/08897077.2015.1062460
Tiet QQ, Leyva Y, Moos RH, Smith B. Diagnostic accuracy of a two-item screen for drug use developed from the alcohol, smoking and substance involvement screening test (ASSIST). Drug and Alcohol Dependence. 2016;164:22-27. DOI: https://doi.org/10.1016/j.drugalcdep.2016.03.029
Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP. Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool. Contemporary Clinical Trials. 2016;50:90-97. DOI: https://doi.org/10.1016/j.cct.2016.07.013
Tiet QQ, Leyva YE, Moos RH, Frayne SM, Osterberg L, Smith B. Screen of drug use: diagnostic accuracy of a new brief tool for primary care. JAMA Intern Med. 2015;175(8):1371-1377.DOI: https://doi.org/10.1001/jamainternmed.2015.2438
Assanangkornchai S, Balthip Q, Edwards JG. Implementing the Alcohol, Smoking, Substance Involvement Screening Test and linked brief intervention service in primary care in Thailand. J Public Health (Oxf). 2014;36(3):443-449. DOI: https://doi.org/10.1093/pubmed/fdu011
Connery HS, Albright BB, Rodolico JM. Adolescent substance use and unplanned pregnancy: strategies for risk reduction. Obstetrics and Gynecology Clinics of North America. 2014;41(2):191-203. DOI: https://doi.org/10.1016/j.ogc.2014.02.011
Gopman S. Prenatal and postpartum care of women with substance use disorders. Obstetrics and Gynecology Clinics of North America. 2014;41(2):213-228. DOI: https://doi.org/10.1016/j.ogc.2014.02.004
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP. Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. Drug and Alcohol Dependence. 2014;140:213-216. DOI: https://doi.org/10.1016/j.drugalcdep.2014.03.034
McNeely J, Strauss SM, Wright S, Rotrosen J, Khan R, Lee JD, et al. Test–retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. Journal of Substance Use & Addiction Treatment. 2014;47(1):93-101. DOI: https://doi.org/10.1016/j.jsat.2014.01.007
McNeely J, Strauss SM, Rotrosen J, Ramautar A, Gourevitch MN. Validation of an audio computer‐assisted self‐interview (ACASI) version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. Addiction. 2014;111(2):233-244. DOI: https://doi.org/10.1111/add.13165
Merrill JO, Duncan MH. Addiction disorders. Medical Clinics of North America. 2014;98(5):1097-1122. DOI: https://doi.org/10.1016/j.mcna.2014.06.008
Saingam D, Assanangkornchai S, Geater AF, Lerkiatbundit S. Validation of Krathom (Mitragyna speciosa Korth.) Dependence Scale (KDS): a dependence screen for internationally emerging psychoactive substance. Subst Abus. 2014;35(3):276-283. DOI: https://doi.org/10.1080/08897077.2014.924464
Saitz R, Cheng DM, Allensworth-Davies D, Winter MR, Smith PC. The ability of single screening questions for unhealthy alcohol and other drug use to identify substance dependence in primary care. Journal of Studies on Alcohol and Drugs. 2014;75(1):153-7. DOI: https://doi.org/10.15288/jsad.2014.75.153
Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155-60. DOI: https://doi.org/10.1001/archinternmed.2010.140
Strobbe S. Prevention and screening, brief intervention, and referral to treatment for substance use in primary care. Prim Care. 2014;41(2):185-213. DOI: https://doi.org/10.1016/j.pop.2014.02.002
Goodyear-Smith F, Warren J, Bojic M, Chong A. eCHAT for lifestyle and mental health screening in primary care. Ann Fam Med. 2013;11(5):460-6. DOI: https://doi.org/10.1370/afm.1512
Goodyear-Smith F, Warren J, Elley CR. The eCHAT program to facilitate healthy changes in New Zealand primary care. J Am Board Fam Med. 2013;26(2):177-82. DOI: https://doi.org/10.3122/jabfm.2013.02.120221
Strobbe S. Addressing substance use in primary care. Nurse Pract. 2013;38(10):45-53. DOI: https://doi.org/10.1097/01.npr.0000433078.14775.15
Tam CWM, Zwar N, Markham R. Australian general practitioner perceptions of the detection and screening of at-risk drinking, and the role of the AUDIT-C: a qualitative study. BMC Fam Pract. 2013;14:121. DOI: https://doi.org/10.1186/1471-2296-14-121
Breuer E, Stoloff K, Myer L, Seedat S, Stein DJ, Joska J. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa. AIDS and Behavior. 2012;16:1464-71. DOI: https://doi.org/10.1007/s10461-011-0067-z
Levy SJ, Kokotailo PK, Committee on Substance Abuse. Substance use screening, brief intervention, and referral to treatment for pediatricians. Pediatrics. 2011;128(5):e1330-e1340. DOI: https://doi.org/10.1542/peds.2011-1754
Madoz-Gúrpide A, Mangado EO. Manejo del consumo de cannabis en población joven en Atención Primaria. Atención Primaria. 2011;43(6):319-324. DOI: https://doi.org/10.1016/j.aprim.2010.10.002
Meltzer EC, Rybin D, Saitz R, Samet JH, Schwartz SL, Butler SF, et al. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain. 2011;152(2):397-402. DOI: https://doi.org/10.1016/j.pain.2010.11.006
Barry KL, Blow FC. Screening, assessing and intervening for alcohol and medication misuse in older adults. In: Handbook of assessment in clinical gerontology. Academic Press. 2010:307-330. DOI: https://doi.org/10.1016/B978-0-12-374961-1.10012-0
Becoña E, López A, del Río EF, Míguez MC, Castro J. Spanish adaptation of the NDSS (Nicotine Dependence Syndrome Scale) and assessment of nicotine-dependent individuals at primary care health centers in Spain. Span J Psychol. 2010;13(2):951-960. DOI: https://doi.org/10.1017/s1138741600002596
Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155-1160. DOI: https://doi.org/10.1001/archinternmed.2010.140
Knight JR, Harris SK, Sherritt L, Van Hook S, Lawrence N, Brooks T, et al. Adolescents' preferences for substance abuse screening in primary care practice. In: Alcohol/Drug Screening and Brief Intervention. CRC Press; 2007:107-117. DOI: https://doi.org/10.1300/j465v28n04_03
Miller WR, Baca C, Compton WM, Ernst D, Manuel JK, Pringle B, et al. Addressing substance abuse in health care settings. Alcohol Clin Exp Res. 2006;30(2):292-302.DOI: https://doi.org/10.1111/j.1530-0277.2006.00027.x.
Harwood GA. Alcohol abuse screening in primary care. The Nurse Practitioner. 2005;30(2):56-61. Available from: https://journals.lww.com/tnpj/citation/2005/02000/alcohol_abuse_screening_in_primary_care.10.aspx
Levy S, Sherritt L, Harris SK, Gates EC, Holder DW, Kulig JW, et al. Test‐retest reliability of adolescents’ self‐report of substance use. Alcohol Clin Exp Res. 2004;28(8):1236-41. DOI: https://doi.org/10.1097/01.ALC.0000134216.22162.A5
Vinson DC, Galliher JM, Reidinger C, Kappus JA. Comfortably engaging: which approach to alcohol screening should we use? Ann Fam Med. 2004;2(5):398-404. DOI: https://doi.org/10.1370/afm.83
Uziel-Miller ND, Dresner N. Addressing substance abuse in obstetrics and gynecology. Prim Care Update Ob Gyns. 2002;9(3):98-104. DOI: https://doi.org/10.1016/S1068-607X(02)00097-5
Knight JR, Goodman E, Pulerwitz T, DuRant RH. Reliability of the Problem Oriented Screening Instrument for Teenagers (POSIT) in adolescent medical practice. Journal of Adolescent Health. 2001;29(2):125-30. DOI: https://doi.org/10.1016/S1054-139X(00)00206-8
Sullivan EJ. A guide to substance abuse services for primary care clinicians. Vol. 97, No. 3139. US Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 1997. Available from: https://www.ncbi.nlm.nih.gov/books/NBK64827/
Butkus R, Rapp K, Cooney TG, Engel LS, Health and Public Policy Committee of the American College of Physicians. Envisioning a better US health care system for all: reducing barriers to care and addressing social determinants of health. Ann Intern Med. 2020;172(2_Supplement). Available from: https://www.acpjournals.org/doi/full/10.7326/M19-2410
Lynch FL, Peterson EL, Lu CY, Hu Y, Rossom RC, Waitzfelder BE, et al. Substance use disorders and risk of suicide in a general US population: a case control study. Addict Sci Clin Pract. 2020;15:1-9. Available from: https://link.springer.com/article/10.1186/s13722-020-0181-1
Devechi ACR, Paiano M, Harmuch C, de Faria MMF, Jaques AE, dos Santos Pini J. O uso de tecnologias digitais em saúde mental na atenção primária à saúde. Ideação. 2024;26(2):5-24. DOI: https://doi.org/10.48075/ri.v26i2.32297
Costa MAF, da Costa MDFB. Replicação das pesquisas científicas no contexto da qualidade: contribuições para estudos em saúde. Humanidades Inov. 2021;8(44):148-57. Disponível em: https://revista.unitins.br/index.php/humanidadeseinovacao/article/view/4892
Mokkink LB, Boers M, Van Der Vleuten CPM, Bouter LM, Alonso J, Patrick DL, et al. COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study. BMC Medical Research Methodology. 2020;20:1-13. DOI: https://doi.org/10.1186/s12874-020-01179-5
Carvajal-Velez L, Ahs JW, Requejo JH, Kieling C, Lundin A, Kumar M, et al. Measurement of mental health among adolescents at the population level: A multicountry protocol for adaptation and validation of mental health measures. J Adolesc Health. 2023;72(1):S27-S33. DOI: https://doi.org/10.1016/j.jadohealth.2021.11.035
Lima JM, Jesus SE, Silva LS, Almeida MASO, Mendonça V, da Rocha EM, et al. Idosos atendidos na atenção primária à saúde com demandas de uso de álcool. Revista Eletrônica Acervo Saúde. 2024;24(10):e16050. DOI: https://doi.org/10.25248/reas.e16050.2024
Goodwin ME, Sayette MA. A social contextual review of the effects of alcohol on emotion. Pharmacology Biochemistry and Behavior. 2022;221:173486. DOI: https://doi.org/10.1016/j.pbb.2022.173486
Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD. Cannabis use and cannabis use disorder. Nat Rev Dis Primers. 2021;7(1):16. DOI: https://doi.org/10.1038/s41572-021-00247-4
Volkow ND, Blanco C. Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023;22(2):203-229. DOI: https://doi.org/10.1002/wps.21073
Al-Worafi YM. Medication abuse and misuse. In: Drug safety in developing countries Drug Safety in Developing Countries; 2020:127-135. DOI: https://doi.org/10.1016/B978-0-12-819837-7.00011-X
Park JN, Rouhani S, Beletsky LE, Vincent L, Saloner B, Sherman SG. Situating the continuum of overdose risk in the social determinants of health: a new conceptual framework. Milbank Q. 2020;98(3):700-746. DOI: https://doi.org/10.1111/1468-0009.12470
Copyright (c) 2025 Universidade Federal de Pelotas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
INSTRUÇÕES: Copiar o texto a seguir em arquivo DOC, preenchendo corretamente o título, imprimir, assinar (todos os autores) e submeter nos ARQUIVOS SUPLEMENTARES o arquivo escaneado em formato PDF, com tamanho máximo de 1MB.
DECLARAÇÃO DE RESPONSABILIDADE E AUTORIA E DE CESSÃO DE DIREITOS AUTORAIS
Submetemos à aprovação do Journal of Nursing and Health (JONAH) o manuscrito "TÍTULO (máximo 15 palavras)", e declaramos que o trabalho é inédito, original e está sendo enviado com exclusividade ao Journal.
Concordamos que em caso de aceitação do manuscrito, os direitos autorais a ele referente passarão a ser propriedade exclusiva do Journal of Nursing and Health (JONAH), sob licença Creative Commons 4.0 e com a divulgação do artigo em mídias sociais da Revista.
Informamos igualmente que todos os procedimentos éticos devidos foram observados, não infringindo nenhum copyright ou nenhum outro tipo de direito de propriedade de outras pessoas e todas as citações no texto são fatos verdadeiros ou baseados em pesquisa de exatidão científica.
Declaramos que cada autor (NOME DOS AUTORES DO MANUSCRITO EM ORDEM) do artigo contribuiu substancialmente para a concepção e planejamento do estudo, seu projeto, obtenção de dados ou análise e interpretação de dados; também contribuiu significativamente com a elaboração do esboço ou a revisão crítica importante do conteúdo intelectual deste manuscrito e aprovou a versão final do manuscrito.
Concordamos em ser responsável por todos os aspectos do trabalho, garantindo à exatidão ou à integridade de qualquer parte da obra.
E por fim, declaramos que FORAM OU NÃO FORAM UTILIZADOS recursos de inteligência artificial para a construção do texto. (CASO TENHA SIDO UTILIZADO ALGUM RECURSO DE IA, INFORMAR SE FOI PARA ESCRITA / MELHORAMENTO DO TEXTO, PRODUÇÃO, ANÁLISE OU GERAÇÃO DE DADOS).
Categoria do artigo: ______________________________
Data: ___/____/____
Nome completo do autor:________________________
Assinatura: ______________________________
Nome completo do autor:________________________
Assinatura: ______________________________
Nome completo do autor:________________________
Assinatura: ______________________________
Nome completo do autor:________________________
Assinatura: ______________________________
Nome completo do autor:________________________
Assinatura: ______________________________
Versão em inglês - English version
INSTRUCTIONS: Copy the following text into a DOC file, correctly filling in the title, printing, signing (all authors) and submitting the scanned file in PDF format to the SUPPLEMENTARY DOCUMENTS, with a maximum size of 1MB.
DECLARATION OF RESPONSIBILITY AND AUTHORSHIP AND COPYRIGHT ASSIGNMENT
We submit the manuscript "TITLE (maximum 15 words)" for approval by the Journal of Nursing and Health (JONAH) and declare that the work is unpublished, original and is being sent exclusively to the Journal. We agree that if the manuscript is accepted, the copyrights related to it will become the exclusive property of the Journal of Nursing and Health (JONAH), under a Creative Commons 4.0 license and with the dissemination of the article on the Journal's social media. We also inform that all due ethical procedures were observed, without infringing any copyright or any other type of property right of other people and all citations in the text are true facts or based on scientifically accurate research. We declare that each author (NAME OF MANUSCRIPT AUTHORS IN ORDER) of the article contributed substantially to the conception and planning of the study, its design, data acquisition or data analysis and interpretation; also contributed significantly to the preparation of the draft or the important critical review of the intellectual content of this manuscript and approved the final version of the manuscript. We agree to be responsible for all aspects of the work, ensuring the accuracy or integrity of any part of the work. And finally, we declare whether artificial intelligence resources WERE OR WERE NOT USED for the construction of the text. (IF ANY AI RESOURCE WAS USED, INFORM WHETHER IT WAS FOR WRITING/IMPROVING THE TEXT, PRODUCTION, ANALYSIS OR DATA GENERATION).
Article Category: ____________________________________________________
Date: ___/____/____
Author's Full Name:____________________________________________
Signature: ________________________________
Author's Full Name:_____________________________________________
Signature: ________________________________
Author's Full Name:_____________________________________________
Signature: ________________________________
Author's Full Name:_____________________________________________
Signature: ________________________________
Author's Full Name:_____________________________________________
Signature: ________________________________
